Remember when we said the Vytorin-cancer thing had quickly faded from view? Turns out it hasn’t disappeared altogether.
The FDA said yesterday that preliminary data from two large, ongoing studies of Vytorin, a cholesterol drug sold by Merck and Schering-Plough, and found no link to cancer.
But the agency also said it expects to get a full [...]
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment